These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11829096)

  • 1. Evaluation of bronchodilator responses in patients with "irreversible" emphysema.
    O'Donnell DE; Forkert L; Webb KA
    Eur Respir J; 2001 Dec; 18(6):914-20. PubMed ID: 11829096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tiotropium and simplified detection of dynamic hyperinflation.
    Gelb AF; Taylor CF; McClean PA; Shinar CM; Rodrigues MT; Gutierrez CA; Chapman KR; Zamel N
    Chest; 2007 Mar; 131(3):690-695. PubMed ID: 17356081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
    Belman MJ; Botnick WC; Shin JW
    Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD.
    Aliverti A; Rodger K; Dellacà RL; Stevenson N; Lo Mauro A; Pedotti A; Calverley PM
    Thorax; 2005 Nov; 60(11):916-24. PubMed ID: 15994253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining Static Hyperinflation in Patients with Severe Emphysema: Relation Between Lung Function Parameters and Patient-Related Outcomes.
    de Weger WW; Klooster K; Ten Hacken NH; van Dijk M; Hartman JE; Slebos DJ
    Lung; 2020 Aug; 198(4):629-636. PubMed ID: 32596757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchodilator response of advanced lung function parameters depending on COPD severity.
    Jarenbäck L; Eriksson G; Peterson S; Ankerst J; Bjermer L; Tufvesson E
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2939-2950. PubMed ID: 27932874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchodilator Responses in Respiratory Impedance, Hyperinflation and Gas Trapping in COPD.
    Milne S; Hammans C; Watson S; Farah CS; Thamrin C; King GG
    COPD; 2018; 15(4):341-349. PubMed ID: 29799289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease.
    Pisi R; Aiello M; Zanini A; Tzani P; Paleari D; Marangio E; Spanevello A; Nicolini G; Chetta A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1191-7. PubMed ID: 26150710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal lung volume changes in patients with chronic obstructive pulmonary disease.
    Lee JS; Kim SO; Seo JB; Lee JH; Kim EK; Kim TH; Kim WJ; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Lee SW; Huh JW; Oh YM; Lee SD
    Lung; 2013 Aug; 191(4):405-12. PubMed ID: 23715996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Spirometric reversibility to salbutamol in chronic obstructive pulmonary disease (COPD). Differential effects on FEV1 and on lung volumes].
    Manríquez J; Díaz O; Borzone G; Lisboa C
    Rev Med Chil; 2004 Jul; 132(7):787-93. PubMed ID: 15379324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Area under the forced expiratory flow-volume loop in spirometry indicates severe hyperinflation in COPD patients.
    Das N; Topalovic M; Aerts JM; Janssens W
    Int J Chron Obstruct Pulmon Dis; 2019; 14():409-418. PubMed ID: 30863041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest.
    Boni E; Corda L; Franchini D; Chiroli P; Damiani GP; Pini L; Grassi V; Tantucci C
    Thorax; 2002 Jun; 57(6):528-32. PubMed ID: 12037229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response patterns to bronchodilator and quantitative computed tomography in chronic obstructive pulmonary disease.
    Lee JS; Huh JW; Chae EJ; Seo JB; Ra SW; Lee JH; Kim EK; Lee YK; Kim TH; Kim WJ; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Sheen SS; Oh YM; Lee SD
    Clin Physiol Funct Imaging; 2012 Jan; 32(1):12-8. PubMed ID: 22152074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity.
    Deesomchok A; Webb KA; Forkert L; Lam YM; Ofir D; Jensen D; O'Donnell DE
    COPD; 2010 Dec; 7(6):428-37. PubMed ID: 21166631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation.
    Newton MF; O'Donnell DE; Forkert L
    Chest; 2002 Apr; 121(4):1042-50. PubMed ID: 11948031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease.
    Hadcroft J; Calverley PM
    Thorax; 2001 Sep; 56(9):713-20. PubMed ID: 11514693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inspiratory capacity and decrease in lung hyperinflation with albuterol in COPD.
    Duranti R; Filippelli M; Bianchi R; Romagnoli I; Pellegrino R; Brusasco V; Scano G
    Chest; 2002 Dec; 122(6):2009-14. PubMed ID: 12475840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fast onset of action of glycopyrronium compared with tiotropium in patients with moderate to severe COPD - A randomised, multicentre, crossover trial.
    Watz H; Mailänder C; May C; Baier M; Kirsten AM
    Pulm Pharmacol Ther; 2017 Feb; 42():13-20. PubMed ID: 27940287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early COPD patients with lung hyperinflation associated with poorer lung function but better bronchodilator responsiveness.
    Chen C; Jian W; Gao Y; Xie Y; Song Y; Zheng J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2519-2526. PubMed ID: 27785008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot comparison of helium dilution and plethysmographic lung volumes to assess the impact of a long-acting bronchodilator on lung hyperinflation in COPD.
    Cazzola M; Rogliani P; Curradi G; Segreti A; Ciaprini C; Pezzuto G; Saltini C
    Pulm Pharmacol Ther; 2009 Dec; 22(6):522-5. PubMed ID: 19481169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.